About Tomorrow Bio
Tomorrow Bio is a Healthcare company based in Berlin (Germany) founded in 2019. Provider of human and pet cryopreservation services. Tomorrow Bio has raised $5.66 million across 1 funding round from investors including Blast Club and TruVenturo. Its website tomorrow.bio draws about 51 thousand monthly visits. Tomorrow Bio offers products and services including Cryopreservation Service, Membership Plan, and Consultation Service. Its focus areas include HealthTech, Healthcare Booking Platforms, Cryopreservation and Body. Its legal entity is Tomorrow Biostasis GmbH.
Company details
Tomorrow Bio was founded in 2019 in Berlin, Germany, within the cryonics sector. Human and pet cryopreservation procedures are offered, covering medical standby, cryoprotection, transport to secure facilities, and indefinite storage in liquid nitrogen. Membership fees are applied to ongoing maintenance and operations, while alternative funding is provided for the procedures themselves. Research aimed at advancing cryonics is conducted by the company.
- Headquarters Berlin, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tomorrow.bio
- Social LinkedIn X Facebook
- Legal Name Tomorrow Biostasis Gmbh
- Total Equity Funding$5.66M (USD)
in 1 rounds
- Latest Funding Round$5.66M (USD), Seed
May 2025
- InvestorsBlast Club
& 1 more
Products & Services of Tomorrow Bio
Tomorrow Bio offers a comprehensive portfolio of products and services, including Cryopreservation Service, Membership Plan, and Consultation Service.
Provides body preservation at low temperatures for future revival possibilities
Offers ongoing medical standby and funding options for cryopreservation
Delivers expert advice on cryonics plans and procedures
Funding Insights of Tomorrow Bio
Tomorrow Bio has successfully raised a total of $5.66M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.66 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.66M
- Total Rounds 1
- Last Round Seed — $5.66M
- First Round $5.66M
(May 2025)
- Investors Count 2
All 1 funding rounds of Tomorrow Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $5.66M | Seed | – | Blast.Club, TruVenturo | – |
2 investors in total: 2 institutional.
Investors in Tomorrow Bio
Tomorrow Bio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Blast Club and TruVenturo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage tech companies in Germany are invested in by TruVenturo. | truventuro.com | Hamburg, Germany | ||
Investments in startups are enabled via a dedicated fundraising platform. | 2022 | blast.club | Paris, France |
Investor details for Tomorrow Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Tomorrow Bio
2 dated milestones of Tomorrow Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Tomorrow Bio is founded.
- Funding First funding round of $5.7M.
Web traffic of Tomorrow Bio
The website of Tomorrow Bio (tomorrow.bio) receives about 50.7K visits a month.
- Monthly visits50.7K
▲ 1.8% vs previous month
Websites whose visitors overlap most with Tomorrow Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cryonics.org | cryonics.org | 100% | #1,724,459 | – | |
i-med.ac.at | i-med.ac.at | 95% | #93,474 | – | |
geneticliteracyproject.org | geneticliteracyproject.org | 95% | #282,804 | – | |
biopharmatrend.com | biopharmatrend.com | 95% | #1,118,765 | – | |
| the-scientist.com | 95% | 333.7K | #165,042 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Tomorrow Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tomorrow Bio
Complete news archive for Tomorrow Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tomorrow Bio
Tomorrow Bio was founded in 2019 and raised its 1st funding round 6 years after it was founded.
Tomorrow Bio is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Tomorrow Bio is a funded company, having raised a total of $5.66M across 1 funding round to date. The company's 1st funding round was a Seed of $5.66M, raised on May 2025.
Tomorrow Bio was founded in 2019 in Berlin, Germany, within the cryonics sector. Human and pet cryopreservation procedures are offered, covering medical standby, cryoprotection, transport to secure facilities, and indefinite storage in liquid nitrogen. Membership fees are applied to ongoing maintenance and operations, while alternative funding is provided for the procedures themselves. Research aimed at advancing cryonics is conducted by the company.
Tomorrow Bio offers Cryopreservation Service, Membership Plan, and Consultation Service.
Tomorrow Bio has 2 investors. Key investors include Blast Club, and TruVenturo.
Tomorrow Bio operates through Tomorrow Biostasis Gmbh.